跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 24 条关于
“Ergomed”
全部
24
临床试验
4
药物
3
机构
5
资讯
12
去年
CEL-SCI Partners with Ergomed for Multikine Confirmatory FDA Registration Study in Head and Neck Cancer
去年
CEL-SCI's Multikine Demonstrates Promising Tumor Regression, Advances to Confirmatory Phase 3 Trial for Head and Neck Cancer
去年
CEL-SCI Advances Multikine for Head and Neck Cancer with FDA-Cleared 212-Patient Registration Study
8个月前
CEL-SCI Advances Multikine Toward Registration with 212-Patient Confirmatory Study for Head and Neck Cancer
去年
CervoMed and Cognition Therapeutics Advance DLB Therapies in Phase II Trials
去年
CervoMed's Neflamapimod Shows Promise in Dementia with Lewy Bodies by Targeting Neurodegenerative Activity
去年
CervoMed Wins Prix Galien USA 2024 for Advances in Dementia with Lewy Bodies Treatment
去年
CervoMed's Neflamapimod Shows Promise in Dementia with Lewy Bodies
去年
CervoMed's Neflamapimod Shows Promise in Dementia with Lewy Bodies Treatment
去年
CervoMed's Neflamapimod Shows Promise in Dementia with Lewy Bodies (DLB) Treatment
第 1 页,共 2 页
上一页
下一页